Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Update on the planned consolidation of UK medicines legislation

November 21, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …
News
Press release

EMA accepts submission of Pfizer’s new arthritis drug

November 21, 2011 Research and Development, Sales and Marketing EMA, Pfizer, tofacitinib

The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …
News
Sweden pic

What does it take to make integrated care work?

November 21, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Feature

Andreas Pott appointed deputy executive director of European Medicines Agency

November 21, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Europe

The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …
Appointment
Avastin picture

FDA pulls Roche’s Avastin for breast cancer

November 21, 2011 Research and Development, Sales and Marketing FDA, Roche, avastin

The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …
News
dipankar_bhattacharjee_teva

Dipankar Bhattacharjee becomes vice president of Teva Northern Europe

November 21, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe. Teva said that as part of …
Appointment

AstraZeneca’s thyroid cancer drug gets CHMP nod

November 21, 2011 Sales and Marketing AstraZeneca, CHMP, Caprelsa, vandetanib

AstraZeneca’s thyroid cancer pill Caprelsa has taken a step closer to European approval after being recommended by the CHMP.Caprelsa (vandetanib) …
News

Industry supports bid to revitalise antibiotic research

November 17, 2011 Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic

The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …
News

Jeremy Poland

November 17, 2011 Sales and Marketing MSI Consultancy

Pharmaceutical consultancy firm The MSI Consultancy has appointed Jeremy Poland as a Graduate Analyst in its Marketing Sciences division. Jeremy …
Appointment

NICE will not back Eisai’s Halaven

November 17, 2011 Medical Communications, Sales and Marketing Eisai, Halaven, NICE, breast cancer

NICE has not recommended Eisai’s novel breast cancer drug Halaven due to concerns over its safety and cost.In draft guidance …
News
life_healthcare_jpg

Life Healthcare makes four new appointments

November 16, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life healthcare communications

Life Healthcare Communications has made four new appointments, adding to its client service, creative and digital teams. Vicki Marsh joins …
Appointment

GSK diabetes drug fails head-to-head against Victoza

November 16, 2011 Sales and Marketing GLP-1, Victoza, albiglutide, diabetes

GlaxoSmithKline’s long-acting diabetes drug albiglutide has failed in a head-to-head trial against Novo Nordisk’s Victoza. Albiglutide is an injectable glucagon-like …
News

Multaq raises risk of death in permanent AF patients

November 16, 2011 Sales and Marketing AF, Multaq, Sanofi

More bad news for Sanofi’s Multaq as new data shows the drug doubles the risk of death in people with …
News
Boehringer pic

Boehringer invests $65 million in early R&D centre

November 16, 2011 Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim is investing $65 million for an early-stage research and development centre in the US. The new 72,000 sq.ft. …
News

Joachim Christ to lead corporate controlling at Merck KGaA

November 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling. Christ, 46, …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026